Fed. Circ. Backs Melinta Patent Win In Injections Case
By Adam Lidgett · June 5, 2026, 5:50 PM EDT
Nexus Pharmaceuticals lost its appeal of an Illinois federal judge's finding that it infringed a pair of patents relating to a line of injections that treat infections, after the Federal Circuit...
To view the full article, register now.